A student-run resource for reliable reports on the latest law and technology news
By Sarah Sorscher*, JD/MPH Candidate, Harvard Law School & Sara Crager, MD/PhD Candidate, Yale Editorial Policy Text of H.R. 1427 Summary Last week, Rep. Henry Waxman and several other representatives unveiled the latest version of a bill designed to lower the price of drugs by encouraging generic competition in biological products (“biologics”). Biologics are products derived from living processes and used to prevent, treat, or cure human illness. Most drugs, in contrast, are synthesized using chemical reactions.  Biologics include products such as vaccines, blood-derived products, antibodies, ... Read More...
Posted On Mar - 19 - 2009 Comments Off READ FULL POST
  • RSS
  • Facebook
  • Twitter
  • GooglePlay
Fed. Cir. Flash Digest

Federal Circuit Flas

By Kayla Haran – Edited by Ken Winterbottom Court Finds Negative ...

Fed. Cir. Flash Digest

Federal Circuit Flas

By Patrick Gallagher – Edited by Ken Winterbottom TOR Project Head ...


Senate passes Cybers

Senate passes Cybersecurity Information Sharing Act By Frederick Ding — Edited by ...

Senate Judiciary Committee

Senators push bill p

By Bhargav Srinivasan – Edited by Olga Slobodyanyuk In October, Senators ...


Federal Circuit Flas

Federal Circuit Flash Digest By Keke Wu – Edited by Yunnan ...